|
Variable
|
Number of subjects (sample size = 3173)
|
Weighted percentages
|
|---|
|
Symptoms
| | |
|
Asymptomatic
|
1001
|
30.9
|
|
Lower urinary alone
|
1832
|
58.4
|
|
Systemic
|
340
|
10.7
|
|
Comorbid conditions
| | |
|
None
|
1211
|
37.2
|
|
1
|
1008
|
32.5
|
|
2
|
520
|
16.3
|
|
3+
|
434
|
13.9
|
|
Health status
| | |
|
Excellent
|
534
|
16.9
|
|
Good
|
2104
|
66.2
|
|
Fair or poor
|
500
|
15.9
|
|
Unknown
|
35
|
1.0
|
|
PSA (ng/ml)
| | |
|
<4
|
294
|
8.8
|
|
≥ 4
|
2675
|
84.5
|
|
Unknown
|
204
|
6.7
|
|
Digital rectal examination
| | |
|
Abnormal
|
1741
|
54.8
|
|
Normal
|
1033
|
33.2
|
|
Unknown
|
399
|
12.0
|
|
Gleason score
| | |
|
2 – 4
|
481
|
13.9
|
|
5 – 7
|
2029
|
65.1
|
|
8 – 10
|
373
|
11.6
|
|
Unknown
|
290
|
9.4
|
|
Tumor stage
| | |
|
Local
|
2796
|
88.7
|
|
Regional
|
126
|
3.7
|
|
Advanced
|
251
|
7.6
|
- Legend: PSA = prostate-specific antigen
